Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan R Young

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Medrxiv : the Preprint Server for Health Sciences|October 27, 2023
Multimodal smoking cessation treatment combining transcranial magnetic stimulation, cognitive behavioral therapy, and nicotine replacement therapy in veterans with posttraumatic stress disorder: A feasibility randomized controlled trial protocolJonathan R Young, Jeffrey T Galla, Carri S Polick, et al.
Journal of Medicinal Chemistry|September 28, 2011
Discovery of 1-amino-5H-pyrido[4,3-b]indol-4-carboxamide inhibitors of Janus kinase 2 (JAK2) for the treatment of myeloproliferative disordersJongwon Lim, Brandon Taoka, Ryan D Otte, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
Identification of neutral 4-O-alkyl quinolone nonpeptide GnRH receptor antagonistsRobert J DeVita, Mamta Parikh, Jinlong Jiang, et al.
Bioorganic & Medicinal Chemistry|February 6, 2008
Fused bicyclic pyrrolizinones as new scaffolds for human NK1 antagonistsGregori J Morriello, Robert J Devita, Sander G Mills, et al.
Plos One|September 6, 2024
Multimodal smoking cessation treatment combining repetitive transcranial magnetic stimulation, cognitive behavioral therapy, and nicotine replacement in veterans with posttraumatic stress disorder: A feasibility randomized controlled trial protocolJonathan R Young, Carri S Polick, Andrew M Michael, et al.
Bioorganic & Medicinal Chemistry Letters|July 20, 2007
The discovery of potent, selective, and orally bioavailable hNK1 antagonists derived from pyrrolidinePeter Lin, Lehua Chang, Robert J Devita, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2002
2-Arylindoles as gonadotropin releasing hormone (GnRH) antagonists: optimization of the tryptamine side chainJonathan R Young, Song X Huang, Thomas F Walsh, et al.
Bioorganic & Medicinal Chemistry Letters|August 22, 2006
2-Aminoquinoline melanin-concentrating hormone (MCH)1R antagonistsJinlong Jiang, Myle Hoang, Jonathan R Young, et al.
Journal of Medicinal Chemistry|November 21, 2017
The Discovery of 3-((4-Chloro-3-methoxyphenyl)amino)-1-((3R,4S)-4-cyanotetrahydro-2H-pyran-3-yl)-1H-pyrazole-4-carboxamide, a Highly Ligand Efficient and Efficacious Janus Kinase 1 Selective Inhibitor with Favorable Pharmacokinetic PropertiesTony Siu, Jason Brubaker, Peter Fuller, et al.
Journal of Medicinal Chemistry|February 6, 2013
Discovery of 1-[3-(1-methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]-N-(pyridin-2-ylmethyl)methanesulfonamide (MK-8033): A Specific c-Met/Ron dual kinase inhibitor with preferential affinity for the activated state of c-MetAlan B Northrup, Matthew H Katcher, Michael D Altman, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Medrxiv : the Preprint Server for Health Sciences|October 27, 2023
Multimodal smoking cessation treatment combining transcranial magnetic stimulation, cognitive behavioral therapy, and nicotine replacement therapy in veterans with posttraumatic stress disorder: A feasibility randomized controlled trial protocolJonathan R Young, Jeffrey T Galla, Carri S Polick, et al.
Journal of Medicinal Chemistry|September 28, 2011
Discovery of 1-amino-5H-pyrido[4,3-b]indol-4-carboxamide inhibitors of Janus kinase 2 (JAK2) for the treatment of myeloproliferative disordersJongwon Lim, Brandon Taoka, Ryan D Otte, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
Identification of neutral 4-O-alkyl quinolone nonpeptide GnRH receptor antagonistsRobert J DeVita, Mamta Parikh, Jinlong Jiang, et al.
Bioorganic & Medicinal Chemistry|February 6, 2008
Fused bicyclic pyrrolizinones as new scaffolds for human NK1 antagonistsGregori J Morriello, Robert J Devita, Sander G Mills, et al.
Plos One|September 6, 2024
Multimodal smoking cessation treatment combining repetitive transcranial magnetic stimulation, cognitive behavioral therapy, and nicotine replacement in veterans with posttraumatic stress disorder: A feasibility randomized controlled trial protocolJonathan R Young, Carri S Polick, Andrew M Michael, et al.
Bioorganic & Medicinal Chemistry Letters|July 20, 2007
The discovery of potent, selective, and orally bioavailable hNK1 antagonists derived from pyrrolidinePeter Lin, Lehua Chang, Robert J Devita, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2002
2-Arylindoles as gonadotropin releasing hormone (GnRH) antagonists: optimization of the tryptamine side chainJonathan R Young, Song X Huang, Thomas F Walsh, et al.
Bioorganic & Medicinal Chemistry Letters|August 22, 2006
2-Aminoquinoline melanin-concentrating hormone (MCH)1R antagonistsJinlong Jiang, Myle Hoang, Jonathan R Young, et al.
Journal of Medicinal Chemistry|November 21, 2017
The Discovery of 3-((4-Chloro-3-methoxyphenyl)amino)-1-((3R,4S)-4-cyanotetrahydro-2H-pyran-3-yl)-1H-pyrazole-4-carboxamide, a Highly Ligand Efficient and Efficacious Janus Kinase 1 Selective Inhibitor with Favorable Pharmacokinetic PropertiesTony Siu, Jason Brubaker, Peter Fuller, et al.
Journal of Medicinal Chemistry|February 6, 2013
Discovery of 1-[3-(1-methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]-N-(pyridin-2-ylmethyl)methanesulfonamide (MK-8033): A Specific c-Met/Ron dual kinase inhibitor with preferential affinity for the activated state of c-MetAlan B Northrup, Matthew H Katcher, Michael D Altman, et al.
Pageof 7